TSF Supervisors Toolkit: Phase II
Award amount
$859,275Program and phase
SBIR · Phase IIAward year
2011Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CBT4CBT LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- CKDVY4EXD6M9
- Solicitation number
- PA10-050
- Topic code
- NIAAA
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A Method to Increase Buprenorphine Treatment Capacity and Effectiveness
- A Method to Increase Buprenorphine Treatment Capacity and Effectiveness
- CBT Supervisor's Toolkit: Phase II
- CBT Supervisor's Toolkit
- TSF Supervisor's Toolkit
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Developing natural compound emodin as a therapy for alcoholic cardiomyopathy
- DEVELOPMENT OF NOVEL PDE4B INHIBITORS TO TREAT ALCOHOL USE DISORDER (SBIR PHASE II)
- SBIR PHASE I - WEARABLE BIOSENSOR THAT QUANTIFIES BLOOD ALCOHOL CONCENTRATION IN REAL TIME
- THIS SBIR PHASE I CONTRACT IS FOR A WEARABLE ALCOHOL BIOSENSOR THAT QUANTIFIES BAC IN REAL TIME.
- Detection and Staging of Liver Fibrosis by Precise MRI (pMRI)
Research funding history
14 SBIR/STTR records share this UEI (1997–2018). Reported award amounts total $6,079,743. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services